Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma
NCT00244764Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of pazopanib in renal cell carcinoma (RCC), sponsored by GSK. Started Oct 2005; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00244764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244764.